Search research articles
Contact Us
Filters
Showing results (91-100 of 167) with videos related to
Page
of 17
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
October 21, 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Ryan M Young, Tianyi Wu, Roland Schmitz, et al.
Blood
|
June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
Lisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
Blood Advances
|
October 15, 2021
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements
Leonie Frauenfeld, Natalia Castrejon-de-Anta, Joan Enric Ramis-Zaldivar, et al.
Genes, Chromosomes & Cancer
|
September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphoma
Lindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 23, 2013
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
Michael Chiorazzi, Lixin Rui, Yandan Yang, et al.
Blood
|
July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
Derville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Blood
|
October 1, 2011
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
Ellen Leich, Alberto Zamo, Heike Horn, et al.
American Journal of Hematology
|
March 18, 2014
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma
Heather L Gustafson, Song Yao, Bryan H Goldman, et al.
Blood
|
July 24, 2019
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
Deborah M Stephens, Hongli Li, Heiko Schöder, et al.
Leukemia & Lymphoma
|
October 6, 2015
Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status
Samantha Kendrick, Katalin Tus, George Wright, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 167) with videos related to
Sort By:
Page
of 17
Proceedings of the National Academy of Sciences of the United States of America
|
October 21, 2015
Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens
Ryan M Young, Tianyi Wu, Roland Schmitz, et al.
Blood
|
June 12, 2008
Gene expression predicts overall survival in paraffin-embedded tissues of diffuse large B-cell lymphoma treated with R-CHOP
Lisa M Rimsza, Michael L Leblanc, Joseph M Unger, et al.
Blood Advances
|
October 15, 2021
Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements
Leonie Frauenfeld, Natalia Castrejon-de-Anta, Joan Enric Ramis-Zaldivar, et al.
Genes, Chromosomes & Cancer
|
September 8, 2007
Frequent occurrence of deletions in primary mediastinal B-cell lymphoma
Lindsey R Kimm, Ronald J deLeeuw, Kerry J Savage, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 23, 2013
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
Michael Chiorazzi, Lixin Rui, Yandan Yang, et al.
Blood
|
July 17, 2008
The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival
Derville O'Shea, Ciarán O'Riain, Claire Taylor, et al.
Blood
|
October 1, 2011
MicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotype
Ellen Leich, Alberto Zamo, Heike Horn, et al.
American Journal of Hematology
|
March 18, 2014
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma
Heather L Gustafson, Song Yao, Bryan H Goldman, et al.
Blood
|
July 24, 2019
Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma
Deborah M Stephens, Hongli Li, Heiko Schöder, et al.
Leukemia & Lymphoma
|
October 6, 2015
Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status
Samantha Kendrick, Katalin Tus, George Wright, et al.
Page
of 17